Flowmedical

Chicago, US · 2 known investors

Flow Medical develops technology for catheter-directed thrombolysis treatment of pulmonary embolism, aiming to improve precision in lytic medication dosing to reduce readmission rates. The company targets interventional cardiologists and radiologists managing acute PE cases.

Digital HealthHealthtechMedical Devices